Predictive and prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancer: a real-world study from Vietnam
Therapeutic Advances in Medical Oncology · 2025-12 · 17
DOI: 10.1177/17588359251403410 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutic Advances in Medical Oncology, online erschienen am 21.12.2025. Verfasst von Linh Dang Ngoc Tran und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, School of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
The clinical validity of tumor-infiltrating lymphocytes (TILs) has been investigated extensively in triple-negative breast cancer (TNBC). However, inconsistent cutoff values across studies limit its clinical application.
Objective
To determine the optimal TILs cutoff predicting pathological complete response (pCR) and event-free survival (EFS) in Vietnamese TNBC patients undergoing neoadjuvant chemotherapy (NACT).
Design
A single-center, retrospective cohort study of 106 stage II–III TNBC patients treated with NACT at Ho Chi Minh City Oncology Hospital between January 2022 and May 2023.
Methods
Stromal TILs (sTILs) were evaluated on pre-treatment biopsy specimens using the International TILs Working Group guideline. The optimal cutoff was determined using receiver operating characteristic curve analysis. Logistic regression and Cox proportional hazards models were used to analyze potentially predictive and prognostic factors.
Results
An optimal 20% TILs cutoff stratified the cohort into high- and low-TIL groups, with significantly different pCR rates (50.9% vs 9.8%, p < 0.001). High TILs (odds ratio (OR) = 8.22, p < 0.001) and lower clinical tumor status (OR = 3.64, p = 0.033) independently predicted pCR. TILs (hazard ratio (HR) = 0.38, p = 0.017) and pCR status (HR = 0.08, p = 0.017) were independent prognostic factors for EFS.
Conclusion
A sTIL cutoff of 20% effectively predicts chemotherapy response and survival outcome in Vietnamese TNBC patients, supporting its use in clinical decision-making.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology, School of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.
- Ho Chi Minh City Oncology Hospital, Ho Chi Minh City, Vietnam.
- Department of Oncology, School of Medicine, University of Medicine and Pharmacy at Ho Chi Minh City, 217 Hong Bang Street, Cho Lon Ward, Ho Chi Minh City, Vietnam.
- Department of Oncology, Pham Ngoc Thach University of Medicine, Ho Chi Minh City, Vietnam.
ORCID-Profile: Kha Kinh Nguyen, Anh Thi Tuyet Cung
Zitieren
APA
Tran, L. D. N., Nguyen, K. K., Pham, T. M., Nguyen, Q. H., Thai, T. A., Phan, D. T. H., & Cung, A. T. T. (2025). Predictive and prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancer: a real-world study from Vietnam. Therapeutic Advances in Medical Oncology, 17. https://doi.org/10.1177/17588359251403410
Vancouver
Tran LDN, Nguyen KK, Pham TM, Nguyen QH, Thai TA, Phan DTH, et al. Predictive and prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancer: a real-world study from Vietnam. Therapeutic Advances in Medical Oncology. 2025;17. doi:10.1177/17588359251403410
BibTeX
@article{Tran2025,
author = {Tran, Linh Dang Ngoc and Nguyen, Kha Kinh and Pham, Tam Minh and Nguyen, Quy Hoang and Thai, Tu Anh and Phan, Duc Thi Hong and Cung, Anh Thi Tuyet},
title = {Predictive and prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancer: a real-world study from Vietnam},
journal = {Therapeutic Advances in Medical Oncology},
year = {2025},
volume = {17},
doi = {10.1177/17588359251403410}
}
EUVIMED